Dr. Desai is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1021 Morehead Medical Dr
Ste A
Charlotte, NC 28204Phone+1 980-442-2000
Summary
- Dr. Payal Desai is a hematologist. She is experienced in sickle cell, thrombotic disorders, and classical hematology.
Education & Training
- University of North Carolina HospitalsFellowship, Hematology and Medical Oncology, 2009 - 2012
- University of Louisville School of MedicineResidency, Internal Medicine, 2006 - 2009
- University of Louisville School of MedicineClass of 2006
Certifications & Licensure
- NC State Medical License 2022 - 2025
- OH State Medical License 2012 - 2025
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
Clinical Trials
- Kidney Function in Sickle Cell Anemia Start of enrollment: 2017 Nov 17
Roles: Sub-Investigator, Contact
- The Predictive Capacity of Machine Learning Models for Progressive Kidney Disease in Individuals With Sickle Cell Anemia Start of enrollment: 2022 Jul 05
Roles: Contact, Sub-Investigator
- Cognitive Behavioral Therapy and Real-Time Pain Management Intervention for Sickle Cell Via Mobile Applications Start of enrollment: 2020 Aug 12
- Join now to see all
Publications & Presentations
PubMed
- Association of biomarkers of endothelial function, coagulation activation and kidney injury with persistent albuminuria in sickle cell anaemia.Laila Elsherif, Yihan Tang, Kammie L Patillo, David Wichlan, Ugochi O Ogu
British Journal of Haematology. 2024-11-01 - Persistent albuminuria and chronic kidney disease in adults with sickle cell anaemia: Results from a multicenter natural history study.Laura Y Zhou, Vimal K Derebail, Payal C Desai, Laila Elsherif, Kammie L Patillo
British Journal of Haematology. 2024-09-01 - 1 citationsRiociguat in patients with sickle cell disease and hypertension or proteinuria (STERIO-SCD): a randomised, double-blind, placebo controlled, phase 1-2 trial.Mark T Gladwin, Victor R Gordeuk, Payal C Desai, Caterina Minniti, Enrico M Novelli
The Lancet. Haematology. 2024-05-01
Abstracts/Posters
- The Effects of Utilization of Individualized Pain Plans in Treatment of Vaso-Occlusive Crises in the Emergency DepartmentPayal Desai, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Chronic Kidney Disease Is Under-Screened in SCD and Mild Albuminuria Is Associated with a Drop in Hemoglobin: A Report from the Grndad Sickle Cell RegistryPayal Desai, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Effect of Age on Healthcare Utilization in Patients with Sickle CellPayal Desai, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Join now to see all
Lectures
- Managing Acute and Chronic Pain in Patients With Sickle Cell Disease60th American Society of Hematology Annual Meeting - 12/3/2018
- Iron Overload Is Under-Recognized and Under-Treated in SCD: A Report from the GRNDaD Registry2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- High-Throughput Mirna Analysis Suggests Pro-Inflammatory Profile in Sickle Cell Disease2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
Press Mentions
- Sickle Cell Disease: No Longer the Road Less TravelledDecember 4th, 2018
- Does This Child Have Both Beta and Alpha Thalassemia Trait?June 2nd, 2016
- ‘Digital Deserts’ Send Doctors Out on House Calls to Fight VirusJune 18th, 2020
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: